Octenidine Hydrochloride in Hydatid Disease

Hydatid disease remains a significant health issue in developing regions, where it causes substantial illness. Current treatments often involve surgical removal of hydatid cysts. However, scolicidal agents are needed to kill the protoscoleces within the cysts during surgery. Prior research has shown that saline solutions have limited effectiveness in this role. This gap motivated the investigation of alternative agents like octenidine hydrochloride. No prior work had resolved the optimal concentration and exposure time for octenidine in this context. The need for a reliable scolicidal agent is clear from the limitations of existing methods. This study aimed to address that need by testing octenidine's effectiveness. Understanding the in vitro behavior of such agents is essential for clinical application. The findings could inform safer and more effective surgical protocols.

The study aimed to evaluate the in vitro scolicidal effects of octenidine hydrochloride at various concentrations and exposure times. Hydatid disease requires effective scolicidal agents to prevent protoscolex survival during surgery. The researchers focused on comparing octenidine with 20% saline, a commonly used alternative. They tested undiluted, 1%, and 0.1% octenidine solutions. Exposure times ranged from 5 to 60 minutes. The goal was to determine the minimum effective concentration and duration. This approach allows for a precise understanding of octenidine's potential use. The study's design reflects the need for practical, evidence-based solutions in clinical settings.

The researchers collected hydatid cyst fluid and allowed it to settle for one hour to obtain cystic sand. They then exposed the sediment to different octenidine concentrations: undiluted, 1%, and 0.1%. Each concentration was tested at multiple exposure times from 5 to 60 minutes. The protoscolex viability was assessed after each exposure. A control group with no treatment and a 20% saline group were included for comparison. The scolicidal effect was measured by observing the protoscolex death rate. The study used a controlled experimental setup to ensure accurate results. This method allowed for a systematic evaluation of octenidine's effectiveness.

Undiluted octenidine showed a strong scolicidal effect after 15 minutes of exposure. This was significantly better than 20% saline at the same time. One percent octenidine achieved a scolicidal effect after 30 minutes of exposure. In contrast, 0.1% octenidine failed to show sufficient effectiveness even after 60 minutes. The protoscolex death rate increased with higher octenidine concentrations and longer exposure times. These findings suggest a dose-dependent relationship. The results highlight the importance of concentration and exposure time. The study provides clear evidence of octenidine's potential as a scolicidal agent.

The authors concluded that undiluted and 1% diluted octenidine may be suitable for scolicidal purposes in hydatid disease treatment. The study demonstrated that these concentrations achieved significant protoscolex death rates. The 0.1% solution did not meet the required effectiveness within one hour. The findings suggest that higher concentrations are more effective. The results align with the need for reliable scolicidal agents in surgical settings. The study supports the use of octenidine as an alternative to saline. The authors propose that these concentrations could be used in clinical practice. The conclusions are based on the observed in vitro effects and comparisons with saline.